Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 92 | ETA2023 | Next issue

45th Annual Meeting of the European Thyroid Association (ETA) 2023

45th Annual Meeting of the European Thyroid Association ETA 2023

Oral Session 9: Thyroid Eye Disease

Previous section
Oral Session 8: Hypothyrodism / Nodules
Table of contents
Next section
Oral Session 10: Novel diagnostics in Thyroid cancer

ea0092op-09-01 | Oral Session 9: Thyroid Eye Disease

VRDN-001, a full antagonist antibody to IGF-1 receptor: in vitro pharmacology and phase 1/2 results in patients with thyroid eye disease (TED)

ea0092op-09-02 | Oral Session 9: Thyroid Eye Disease

Preclinical pharmacokinetics and clinical exposure prediction for VRDN-003, a next-generation half-life extended antibody to the IGF-1 receptor for thyroid eye disease

ea0092op-09-03 | Oral Session 9: Thyroid Eye Disease

Linsitinib, AN IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

ea0092op-09-04 | Oral Session 9: Thyroid Eye Disease

Novel, rapid, sensitive bioassay for thyrotropin receptor stimulatory antibodies- a multicenter, single blind study

ea0092op-09-05 | Oral Session 9: Thyroid Eye Disease

Clinical and visual outcomes of dysthyroid optic neuropathy after surgical orbital decompression

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more